Evidence map›Paper›PMID 42347670›Full record

ArticleVaccines2026

Insights from 25 Years of Measles and Measles-Rubella Vaccination Campaigns in the WHO African Region (2001-2025).

Balcha Girma Masresha, Goitom Gebremedhin Weldegebriel, Emmaculate Jepkorir Lebo, Sarah Wanyoike, Ado Mpia Bwaka, Yolande Vuo-Masembe

Abstract read
In one paragraph

Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Balcha Girma MasreshaWorld Health Organization Regional Office for Africa, Brazzaville P.O. Box 06, Congo.ORCID 0000-0003-3028-887X
Goitom Gebremedhin WeldegebrielWorld Health Organization Inter-Country Support Team for Eastern and Southern Africa, Harare P.O. Box CY 348, Zimbabwe.ORCID 0000-0002-0535-3484
Emmaculate Jepkorir LeboIndependent Consultant.
Sarah WanyoikeWorld Health Organization Inter-Country Support Team for Eastern and Southern Africa, Harare P.O. Box CY 348, Zimbabwe.
Ado Mpia BwakaWorld Health Organization Inter-Country Support Team for Western Africa, Ouagadougou P.O. Box 7019, Burkina Faso.ORCID 0009-0000-1145-8584
Yolande Vuo-MasembeWorld Health Organization Inter-Country Support Team for Central Africa, Libreville, Gabon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe WHO African Region is working to eliminate measles and rubella in 80% of countries by 2030. In countries with sub-optimal routine immunization coverage, periodic supplemental Immunization Activities (SIAs) are implemented to boost childhood immunity against measles and rubella.

methodsWe reviewed the SIA technical reports and reports from post-campaign surveys shared by countries with the WHO Regional Office for Africa, and we analyzed the coverage data from preventive measles campaigns implemented during the years 2001-2025.

resultsA total of 326 preventive measles/measles-rubella SIAs were implemented across 44 countries in the years 2001-2025, providing more than 1.5 billion doses of vaccine to eligible children according to the type and scale of the campaigns. Four fifths (82%) of the SIAs were nationwide exercises, and all of the SIAs were implemented as non-selective vaccination campaigns targeting all eligible children irrespective of past vaccination history, with the exception of four SIAs. The 95% administrative SIA coverage target at national level was met in 209 SIAs (64.7%). At district level, 11 of 164 SIAs had 100% of districts attaining 95% administrative coverage. Only 94 SIAs (29%) were followed by post-campaign coverage survey, and only 18 (19%) of these attained coverage of 95% or more by survey. Nearly two thirds (62%) of the 272 SIAs implemented during 2006-2025 had at least one additional intervention included with the measles/MR vaccination. DISCUSSION: Measles and MR vaccination campaigns have served as excellent opportunities for providing integrated child survival interventions in the African Region. While two thirds of the SIAs met the national administrative coverage target, district-level coverage targets were not met in the majority of the SIAs, and only one fifth of the SIAs met the national-level survey coverage targets. Moreover, discrepancies were noted between administrative and survey coverage results, possibly due to inaccuracies in the reporting of the number of doses administered and/or reliance on inaccurate denominators. For optimal impact, SIAs need to adequately reach unreached populations.

conclusionsIn view of the documented sub-optimal coverage, countries should provide strong leadership and ownership of the measles elimination strategies for the attainment of the SIA coverage targets as well as the overall measles and rubella elimination goal. There is an urgent need for improved tools to identify unvaccinated children, high-risk populations, and innovative strategies to reach them. All countries implementing SIAs should also include systematic monitoring of zero-dose children, and conduct post-campaign coverage surveys in a timely manner.

Indexed as

African Regioneliminationmass campaignsmeaslesrubellasupplemental immunization activities

Identifiers

PMID42347670
PMCPMC13307578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.